AT Kearney
Latest
NACDS is all In on new strategy
The change means ‘moving faster, investing differently, supporting members more directly and building new capabilities.’
New PAINWeek 2026 evidence reveals lasting post-surgical pain relief with TYLENOL and Naproxen
A first-of-its-kind, non-opioid OTC option for the millions managing persistent pain, is backed by more than a decade of research, including Phase 3 data to be presented at PAINWeek.
A list notable for its absences
David Pinto looks at how the Fortune 500 list has changed drastically over the years.